Clinical Trials Browser

Unknown × Carcinoma, Neuroendocrine × Everolimus × Clear all

NCT02687958 2023-05-30

Study of Everolimus as Maintenance Therapy for Metastatic NEC With Pulmonary or Gastroenteropancreatic Origin

Phase 2 Unknown

Carcinoma, Neuroendocrine

NCT02695459 2021-04-20

Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin

Phase 2 Unknown

Carcinoma, Neuroendocrine